Macrogen selects the first stage of a national project that leads to the convergence of AI-based customized care services with Gangbuk Samsung Hospital
Sep 17, 2025
|
Organized by the Ministry of Science and ICT and the Institute of Information and Communication Planning and Evaluation (IITP), the national task aims to implement the 'AI (Agentic AI) Life Care Service' that allows all citizens to continue a healthy life through AI-based medical services under the theme of 'Penom Data-Based AI Life Cycle Health Risk Prediction and Management Ultra-Gap Technology Development'. The key is to develop a model for predicting complications for each disease group and to lay the technical foundation for providing personalized medical services without physical movement of data.
The project will be operated at 3 billion won for the first two years, and the second phase of the study will allow one team selected in the first phase to conduct additional research for two years with 8 billion won in research funds. A total of nine organizations, including Macrogen and Gangbuk Samsung Hospital, Seoul St. Mary's Hospital, Sungkyunkwan University, NAVER Cloud, Samsung Electronics, Weissen, Micro Information Technology, and Digital Farm, will participate in the project as a consortium, and Professor Kang Jae-hun of Gangbuk Samsung Hospital was in charge of the general manager.
About 40 people, including representatives from nine participating organizations, research managers, and IITP officials, attended the official launch ceremony of the project, which was held at Gangbuk Samsung Hospital on the 10th, and Chairman Macrogen Seo Jeong-sun was also present. The launch ceremony was held with the launch of the project group and a kick-off meeting of the consortium.
In this project, Macrogen will conduct key research such as ▲ Production and Analysis of Forward-type Microarray ▲ Retrospective Data Analysis ▲ Construction of a disease-specific phenome-based risk indicator system ▲ Development of Polygenic Risk Score (PRS) algorithm ▲ Integrated multi-dimensional data analysis. In particular, it plans to contribute to the implementation of next-generation AI healthcare based on its 28 years of accumulated dielectric analysis experience and bio big data and AI technology.
"This contract is an important opportunity for Macrogen's genetic analysis and AI convergence technology to be recognized as a key technology in public health management. Through close cooperation with medical institutions, universities, and ICT companies, we will establish the foundation for next-generation AI (Agentic AI) life care services that all citizens can enjoy a healthy life." he said.
This article was translated by Naver AI translator.
